Cited by 328Iron Metabolism and DisordersErythropoietin and Anemia TreatmentHemoglobin structure and function

The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.

Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis

Open access

Liu, Qingdu, Davidoff, Olena, Niss, Knut, Haase, Volker H.·2012·Journal of Clinical Investigation

Open this paper in CoChat — free account

Abstract

Iron demand in bone marrow increases when erythropoiesis is stimulated by hypoxia via increased erythropoietin (EPO) synthesis in kidney and liver. Hepcidin, a small polypeptide produced by hepatocytes, plays a central role in regulating iron uptake by promoting internalization and degradation of ferroportin, the only known cellular iron exporter. Hypoxia suppresses hepcidin, thereby enhancing intestinal iron uptake and release from internal stores. While HIF, a central mediator of cellular adaptation to hypoxia, directly regulates renal and hepatic EPO synthesis under hypoxia, the molecular basis of hypoxia/HIF-mediated hepcidin suppression in the liver remains unclear. Here, we used a genetic approach to disengage HIF activation from EPO synthesis and found that HIF-mediated suppression of the hepcidin gene (Hamp1) required EPO induction. EPO induction was associated with increased erythropoietic activity and elevated serum levels of growth differentiation factor 15. When erythropoiesis was inhibited pharmacologically, Hamp1 was no longer suppressed despite profound elevations in serum EPO, indicating that EPO by itself is not directly involved in Hamp1 regulation. Taken together, we provide in vivo evidence that Hamp1 suppression by the HIF pathway occurs indirectly through stimulation of EPO-induced erythropoiesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci63924

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251 · cited 6×
“The activity of HIF is controlled by O 2 -, iron, and ascorbate-dependent dioxygenases, also known as prolyl-hydroxy-lase domain–containing proteins 1–3 (PHD1–3), which use 2-oxo-glutarate as substrate for the hydroxylation of specific proline residues in HIF-α .”
Influential
Simplified mammalian DNA isolation procedure
Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R., & Berns, A. J. M. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.15.4293 · Cited by 1,497
The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation
Nicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026 · cited 1×
“…transferrin receptor 1 (TRFC) and transferrin receptor 2 (TFR2) (2, 11, 12), or hemojuvelin (HJV), which acts as a coreceptor for bone morphogenetic protein 6 (BMP6), increases hepcidin expression in a mothers against decapen-taplegic homolog–dependent (SMAD-dependent) fashion (13–15).”
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., et al. (2007) · Nature Medicine · doi:10.1038/nm1629 · Cited by 854
Deletion of the Developmentally Essential Gene ATR in Adult Mice Leads to Age-Related Phenotypes and Stem Cell Loss
Ruzankina, Y., Pinzon‐Guzman, C., Asare, A., Ong, T., Pontano, L. L., Cotsarelis, G., Zediak, V. P., Velez, M., Bhandoola, A., & Brown, E. J. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.03.002 · Cited by 803
BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism
Andriopoulos Jr, B., Corradini, E., Xia, Y., Faasse, S. A., Chen, S., Grgurevic, L., Knutson, M. D., Pietrangelo, A., Vukicevic, S., Lin, H. Y., et al. (2009) · Nature Genetics · doi:10.1038/ng.335 · Cited by 769
High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq
Schödel, J., Oikonomopoulos, S., Ragoussis, J., Pugh, C. W., Ratcliffe, P. J., & Mole, D. R. (2011) · Blood · doi:10.1182/blood-2010-10-314427 · Cited by 724
Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)
Peyssonnaux, C., Zinkernagel, A. S., Schuepbach, R. A., Rankin, E., Vaulont, S., Haase, V. H., Nizet, V., & Johnson, R. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31370 · Cited by 639
Self-citation
Forging a field: the golden age of iron biology.
Andrews, N. C. (2008) · Blood · doi:10.1182/blood-2007-12-077388 · Cited by 623

Show all 51 references

Research works printed but not linked: 2

Tanno, 2010, Curr Opin Hematol., 17, 184
Hickey, 2007, J Clin Invest., 12, 3879

Sorted by citations

Items 101–200 of 328

Amelioration of chronic kidney disease-associated anemia by vadadustat in mice is not dependent on erythroferrone
Hanudel, M. R., Wong, S. F., Jung, G., Qiao, B., Gabayan, V. R., Zuk, A., & Ganz, T. (2021) · Kidney International · doi:10.1016/j.kint.2021.03.019 · Cited by 38
EPO synthesis induced by HIF‐PHD inhibition is dependent on myofibroblast transdifferentiation and colocalizes with non‐injured nephron segments in murine kidney fibrosis
Kobayashi, H., Davidoff, O., Pujari‐Palmer, S., Drevin, M., & Haase, V. H. (2022) · Acta Physiologica · doi:10.1111/apha.13826 · Cited by 38
Self-citation
Kynurenine, by activating aryl hydrocarbon receptor, decreases erythropoietin and increases hepcidin production in HepG2 cells: A new mechanism for anemia of inflammation
Eleftheriadis, T., Pissas, G., Antoniadi, G., Liakopoulos, V., & Stefanidis, I. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.08.010 · Cited by 34
Hemorrhage Exacerbates Radiation Effects on Survival, Leukocytopenia, Thrombopenia, Erythropenia, Bone Marrow Cell Depletion and Hematopoiesis, and Inflammation-Associated microRNAs Expression in Kidney
Kiang, J. G., Smith, J. T., Anderson, M. N., Swift, J. M., Christensen, C. L., Gupta, P., Balakathiresan, N. S., & Maheshwari, R. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139271 · Cited by 35
Regulation of iron homeostasis: Lessons from mouse models
Altamura, S., Marques, O., Colucci, S., Mertens, C., Alikhanyan, K., & Muckenthaler, M. U. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100872 · Cited by 35
Iron and colorectal cancer: evidence from in vitro and animal studies
Padmanabhan, H., Brookes, M., & Iqbal, T. H. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuu015 · Cited by 35
Triad role of hepcidin, ferroportin, and Nrf2 in cardiac iron metabolism: From health to disease
Jayakumar, D., Narasimhan, K. K. S., & Kalaiselvi, P. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126882 · Cited by 34
Influence of post-exercise hypoxic exposure on hepcidin response in athletes
Badenhorst, C. E., DAWSON, B. T., Goodman, C., Sim, M., Cox, G. R., Gore, C. J., Tjalsma, H., Swinkels, D. W., & Peeling, P. (2014) · European Journal of Applied Physiology · doi:10.1007/s00421-014-2829-6 · Cited by 35
Iron Regulation by Molidustat, a Daily Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, in Patients with Chronic Kidney Disease
Akizawa, T., Macdougall, I. C., Berns, J. S., Yamamoto, H., Taguchi, M., Iekushi, K., & Bernhardt, T. (2019) · The Nephron journals/Nephron journals · doi:10.1159/000502012 · Cited by 33
Signaling Integration of Hydrogen Sulfide and Iron on Cellular Functions
Arif, H. M., Qian, Z., & Wang, R. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0203 · Cited by 33
Hypoxia-Induced Signaling in Gut and Liver Pathobiology
Solanki, S. A., & Shah, Y. M. (2023) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051122-094743 · Cited by 34
Iron and oxygen sensing: a tale of 2 interacting elements?
Simpson, R. J., & McKie, A. T. (2014) · Metallomics · doi:10.1039/c4mt00225c · Cited by 32
The efficacy and safety of roxadustat for anemia in patients with chronic kidney disease: a meta-analysis
Zheng, Q., Yang, H., Fu, X., Huang, Y., Wei, R., Wang, Y., Liu, Y., & Liu, W. J. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa110 · Cited by 34
Iron dysregulation in COVID‐19 and reciprocal evolution of SARS‐CoV‐2: Natura nihil frustra facit
Gupta, Y., Maciorowski, D., Medernach, B., Becker, D. P., Durvasula, R., Libertin, C. R., & Kempaiah, P. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30207 · Cited by 33
A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis
Gutschow, P., Schmidt, P. J., Han, H., Ostland, V., Bartnikas, T. B., Pettiglio, M. A., Herrera, C., Butler, J. S., Nemeth, E., Ganz, T., et al. (2014) · Haematologica · doi:10.3324/haematol.2014.116723 · Cited by 31
The relationship between systemic iron homeostasis and erythropoiesis
Rishi, G., & Subramaniam, V. N. (2017) · Bioscience Reports · doi:10.1042/bsr20170195 · Cited by 35
Does Hypoxia Cause Carcinogenic Iron Accumulation in Alcoholic Liver Disease (ALD)?
da Silva, I. S., Rausch, V., Seitz, H. K., & Mueller, S. (2017) · Cancers · doi:10.3390/cancers9110145 · Cited by 31
Effects of macro- and micronutrients on exercise-induced hepcidin response in highly trained endurance athletes
Dahlquist, D. T., Stellingwerff, T., Dieter, B. P., McKenzie, D. C., & Koehle, M. S. (2017) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2017-0207 · Cited by 31
Iron, oxygen, and the pulmonary circulation
Frise, M. C., & Robbins, P. A. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00179.2015 · Cited by 31
Treatment of renal anemia: Erythropoiesis stimulating agents and beyond
Biggar, P. H., & Kim, G. (2017) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.2017.36.3.209 · Cited by 31
Novel insights into alcoholic liver disease: Iron overload, iron sensing and hemolysis
Mueller, S., Chen, C., Mueller, J. H., & Wang, S. (2022) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2021-0056 · Cited by 30
Hepcidin and ferritin levels as markers of immune cell activation during septic shock, severe COVID-19 and sterile inflammation
Hortová-Kohoutková, M., Skotáková, M., Onyango, I. G., Slezáková, M., Panovský, R., Opatřil, L., Slanina, P., Zuani, M. D., Mrkva, O., Andrejčinová, I., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1110540 · Cited by 28
A Hypoxia-Inducible Factor Stabilizer Improves Hematopoiesis and Iron Metabolism Early after Administration to Treat Anemia in Hemodialysis Patients
Ogawa, C., Tsuchiya, K., Tomosugi, N., & Maeda, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197153 · Cited by 29
Association of iron-related biomarkers with severity and mortality in COVID-19 patients
Yadav, D., Kumar, P. K., Tomo, S., Sankanagoudar, S., Charan, J., Purohit, A. H. L., Nag, V., Bhatia, P. K., Singh, K., Dutt, N., et al. (2022) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2022.127075 · Cited by 28
Effectiveness of hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat on renal anemia in non-dialysis-dependent chronic kidney disease: a systematic review and meta-analysis
Jia, L., Dong, X., Yang, J., Jia, R., & Zhang, H. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.12.18 · Cited by 27
Effect of hypoxia-inducible factor-prolyl hydroxylase inhibitors on anemia in patients with CKD: a meta-analysis of randomized controlled trials including 2804 patients
Wang, B., Yin, Q., Han, Y., Wu, M., Li, Z., Tu, Y., Zhou, L., Wei, Q., Liu, H., Tang, R., et al. (2020) · Renal Failure · doi:10.1080/0886022x.2020.1811121 · Cited by 26
Apolipoprotein E deficiency induces a progressive increase in tissue iron contents with age in mice
Ma, J., Qian, C., Bao, Y., Liu, M., Ma, H., Shen, M., Li, W., Wang, J., Bao, Y.-X., Liu, Y., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101865 · Cited by 27
The Impact of Iron Dyshomeostasis and Anaemia on Long-Term Pulmonary Recovery and Persisting Symptom Burden after COVID-19: A Prospective Observational Cohort Study
Sonnweber, T., Grubwieser, P., Sahanic, S., Boehm, A., Pizzini, A., Luger, A. K., Schwabl, C., Koppelstätter, S., Kurz, K., Puchner, B., et al. (2022) · Metabolites · doi:10.3390/metabo12060546 · Cited by 29
Characterization of Putative Erythroid Regulators of Hepcidin in Mouse Models of Anemia
Mirciov, C. S. G., Wilkins, S. J., Dunn, L. A., Anderson, G. J., & Frazer, D. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171054 · Cited by 26
Circulating factors are involved in hypoxia-induced hepcidin suppression
Ravasi, G., Pelucchi, S., Greni, F., Mariani, R., Giuliano, A., Parati, G., Silvestri, L., & Piperno, A. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.06.006 · Cited by 25
The problem with transferrin saturation as an indicator of iron ‘sufficiency’ in chronic kidney disease
Besarab, A., & Drüeke, T. B. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa048 · Cited by 28
Drugs activating hypoxia-inducible factors correct erythropoiesis and hepcidin levels via renal EPO induction in mice
Nakai, T., Iwamura, Y., Kato, K., Hirano, I., Matsumoto, Y., Tomioka, Y., Yamamoto, M. P., & Suzuki, N. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023009798 · Cited by 25
GDF15 Is Related to Anemia and Hepcidin in Kidney Allograft Recipients
Małyszko, J., Koc‐Żórawska, E., Małyszko, J. S., Głowińska, I., Myśliwiec, M., & Macdougall, I. C. (2013) · Nephron Clinical Practice · doi:10.1159/000351810 · Cited by 24
Reciprocal regulation between hepcidin and erythropoiesis and its therapeutic application in erythroid disorders
Wang, C., Fang, Z., Zhu, Z., Liu, J., & Chen, H. (2017) · Experimental Hematology · doi:10.1016/j.exphem.2017.05.002 · Cited by 25
Pharmacological inhibition of prolyl hydroxylase protects against inflammation-induced anemia via efficient erythropoiesis and hepcidin downregulation
Jain, M. R., Joharapurkar, A. A., PATEL, V. G., Kshirsagar, S. G., Sutariya, B., Patel, M. S., Patel, H., & Patel, P. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.11.023 · Cited by 25
Iron Mining for Erythropoiesis
Correnti, M., Gammella, E., Cairo, G., & Recalcati, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105341 · Cited by 30
Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease
Koury, M. J., Agarwal, R., Chertow, G. M., Eckardt, K., Fishbane, S. N., Ganz, T., Haase, V. H., Hanudel, M. R., Parfrey, P. S., Pérgola, P. E., et al. (2022) · American Journal of Hematology · doi:10.1002/ajh.26644 · Cited by 25
Self-citation
Hepcidin in Iron Homeostasis: Diagnostic and Therapeutic Implications in Type 2 Diabetes Mellitus Patients
Ambachew, S., & Biadgo, B. (2017) · Acta Haematologica · doi:10.1159/000481391 · Cited by 23
Signaling pathways regulating hepcidin
Rishi, G., & Subramaniam, V. N. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.01.003 · Cited by 23
Hepcidin regulation in a mouse model of acute hypoxia
Ravasi, G., Pelucchi, S., Comani, G. B., Greni, F., Mariani, R., Pelloni, I., Bombelli, S., Perego, R., Barisani, D., & Piperno, A. (2018) · European Journal Of Haematology · doi:10.1111/ejh.13062 · Cited by 22
Influence of iron manipulation on hypoxic pulmonary vasoconstriction and pulmonary reactivity during ascent and acclimatization to 5050 m
Willie, C. K., Patrician, A., Hoiland, R. L., Williams, A. M., Gasho, C., Subedi, P., Anholm, J. D., Drane, A. L., Tymko, M. M., Nowak‐Flück, D., et al. (2021) · The Journal of Physiology · doi:10.1113/jp281114 · Cited by 25
Hepcidin in chronic kidney disease anemia
Santos‐Silva, A., Ribeiro, S., Reis, F., & Belo, L. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.01.012 · Cited by 23
Iron biology
Vecchio, L. D., Girelli, D., Vinchi, F., Cozzolino, M. G., Elliott, S., Mark, P. B., Valenti, L. V. C., Qian, C., Guo, Q., Qian, Z., et al. (2024) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfae095 · Cited by 22
Pathophysiology of Iron Homeostasis during Inflammatory States
Cherayil, B. J. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.07.015 · Cited by 24
The Zinc Finger of Prolyl Hydroxylase Domain Protein 2 Is Essential for Efficient Hydroxylation of Hypoxia-Inducible Factor α
Arsenault, P. R., Song, D., Chung, Y. J., Khurana, T. S., & Lee, F. S. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00090-16 · Cited by 24
Hypoxia-inducible factor prolyl hydroxylase inhibitors: a paradigm shift for treatment of anemia in chronic kidney disease?
Souza, E., Cho, K. H., Harris, S. T., Flindt, N. R., Watt, R. K., & Pai, A. B. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1777276 · Cited by 21
An evaluation of roxadustat for the treatment of anemia associated with chronic kidney disease
Kurata, Y., Tanaka, T., & Nangaku, M. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1993821 · Cited by 22
Iron disorders and hepcidin
Rana, S., & Prabhakar, N. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.10.032 · Cited by 21
Updated perspective of EPAS1 and the role in pulmonary hypertension
Wang, N., Hua, J., Fu, Y., An, J., Chen, X., Wang, C., Zheng, Y., Wang, F., Ji, Y., & Li, Q. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1125723 · Cited by 20
Micronutrients and Breast Cancer Progression: A Systematic Review
Cuenca-Micó, O., & Aceves, C. (2020) · Nutrients · doi:10.3390/nu12123613 · Cited by 23
Determinants of hepcidin levels in sepsis-associated acute kidney injury: Impact on pAKT/PTEN pathways?
Schaalan, M. F., & Mohamed, W. A. (2016) · Journal of Immunotoxicology · doi:10.1080/1547691x.2016.1183733 · Cited by 20
Bone morphogenetic protein-binding endothelial regulator of liver sinusoidal endothelial cells induces iron overload in a fatty liver mouse model
Hasebe, T., Tanaka, H., Sawada, K., Nakajima, S., Ohtake, T., Fujiya, M., & Kohgo, Y. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1237-6 · Cited by 20
Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for β-Thalassemia Patients
Saad, H. K. M., Rahman, A. A. A., Ghani, A. S. A., Taib, W. R. W., Ismail, I., Johan, M. F., Al-wajeeh, A. S., & Al‐Jamal, H. A. N. (2022) · Biomedicines · doi:10.3390/biomedicines10010189 · Cited by 22
The value of soluble transferrin receptor and hepcidin in the assessment of iron status in children with cystic fibrosis
Uijterschout, L., Swinkels, D. W., Akkermans, M. D., Zandstra, T., Nuijsink, M., Hendriks, D. M., Hudig, C., Tjalsma, H., Vos, R. C., van Goudoever, J. B., et al. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.03.007 · Cited by 19
Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial
Singh, A. K., Blackorby, A., Čižman, B., Carroll, K., Cobitz, A. R., Davies, R., Jha, V., Johansen, K. L., Lópes, R. D., Kler, L., et al. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab065 · Cited by 19
Host and microbiota derived extracellular vesicles: Crucial players in iron homeostasis
Daou, Y., Falabrègue, M., Pourzand, C., Peyssonnaux, C., & Edeas, M. A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.985141 · Cited by 19
Effects of hypoxia-inducible factor prolyl hydroxylase inhibitors versus erythropoiesis-stimulating agents on iron metabolism and inflammation in patients undergoing dialysis: A systematic review and meta-analysis
Zheng, Q., Zhang, P., Yang, H., Geng, Y., Tang, J., Kang, Y., Qi, A., & Li, S. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15310 · Cited by 19
HIF-1 contributes to autophagy activation via BNIP3 to facilitate renal fibrosis in hypoxia in vitro and UUO in vivo
Liu, J., Livingston, M. J., Dong, G., Wei, Q., Zhang, M., Mei, S., Zhu, J., Zhang, C., & Dong, Z. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00458.2023 · Cited by 17
Hypoxia induced changes in expression of proteins involved in iron uptake and storage in cultured lens epithelial cells
Goralska, M., Fleisher, L. N., & McGahan, M. C. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.05.010 · Cited by 17
Novel Masters of Erythropoiesis: Hypoxia Inducible Factors and Recent Advances in Anemia of Renal Disease
Solak, Y., Cetiner, M., Siriopol, D. C., Tarım, K., Afşar, B., Covic, A. C., & Kanbay, M. (2016) · Blood Purification · doi:10.1159/000446273 · Cited by 17
The insights into molecular pathways of hypoxia‐inducible factor in the brain
Ostrowski, R. P., & Zhang, J. H. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24366 · Cited by 17
Serum hepcidin levels in chronic liver disease: a systematic review and meta-analysis
Sharma, R., Zhao, W., Zafar, Y., Murali, A. R., & Brown, K. E. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-0540 · Cited by 16
Hepcidin and its potential clinical utility
Miseta, A., Nagy, J., Nagy, T., Poór, V. S., Fekete, Z., & Sipos, K. (2015) · Cell Biology International · doi:10.1002/cbin.10505 · Cited by 16
Increased Hepcidin Levels During a Period of High Training Load Do Not Alter Iron Status in Male Elite Junior Rowers
Zügel, M., Treff, G., Steinacker, J. M., Mayer, B., Winkert, K., & Schümann, U. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01577 · Cited by 15
New perspectives on the molecular basis of the interaction between oxygen homeostasis and iron metabolism
Cairo, G., Recalcati, S., & Gammella, E. (2015) · Hypoxia · doi:10.2147/hp.s83537 · Cited by 17
Mutual Cross Talk Between Iron Homeostasis and Erythropoiesis
Rybińska, I., & Cairo, G. (2017) · Vitamins and hormones · doi:10.1016/bs.vh.2017.01.001 · Cited by 18
Osteopontin deletion drives hematopoietic stem cell mobilization to the liver and increases hepatic iron contributing to alcoholic liver disease
Magdaleno, F., Ge, X., Fey, H., Lu, Y., Gaskell, H., Blajszczak, C. C., Aloman, C., Fiel, M. I., & Nieto, N. (2017) · Hepatology Communications · doi:10.1002/hep4.1116 · Cited by 16
Chronic hypoxia has differential effects on constitutive and antigen-stimulated immune function in Atlantic salmon (Salmo salar)
Rojas, I., de Mello, M. M. M., Zanuzzo, F. S., Sandrelli, R. M., Peroni, E. D. F. C., Hall, J. R., Rise, M. L., Urbinati, E. C., & Gamperl, A. K. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1545754 · Cited by 17
Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant
Pirotte, M., Fillet, M., Seidel, L., Jaspers, A., Baron, F., & Beguin, Y. P. (2021) · American Journal of Hematology · doi:10.1002/ajh.26300 · Cited by 16
Hypoxia-inducible factor upregulation by roxadustat attenuates drug reward by altering brain iron homoeostasis
Yan, P., Li, N., Ma, M., Liu, Z., Yang, H., Li, J., Wan, C., Gao, S., Li, S., Zheng, L. T., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01578-2 · Cited by 15
‘3D-QSAR-based, pharmacophore modelling, virtual screening, and molecular docking studies for identification of hypoxia-inducible factor-1 inhibitor with potential bioactivity
Yadav, P. K., Singh, S., & Singh, A. K. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107557 · Cited by 15
Suppression of plasma hepcidin by venesection during steady-state hypoxia
Talbot, N. P., Smith, T. G., Lakhal‐Littleton, S., Gülsever, C. İ., Rivera, M. C., Dorrington, K. L., Mole, D. R., & Robbins, P. A. (2016) · Blood · doi:10.1182/blood-2015-05-647404 · Cited by 15
Current Status of Renal Anemia Pharmacotherapy—What Can We Offer Today
Borawski, B., Małyszko, J. S., Kwiatkowska, M., & Małyszko, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184149 · Cited by 16
SAR study of 1,2-benzisothiazole dioxide compounds that agonize HIF-2 stabilization and EPO production
Song, W., Zhuang, J., Zhang, N., Ren, X., Xu, W., Guo, M., Diao, X., Liu, C., Jin, J., Wu, D., et al. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.117041 · Cited by 15
Efficacy and Safety of Vadadustat for Anemia in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Xiong, L., Zhang, H., Guo, Y., Song, Y., & Tao, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.795214 · Cited by 14
Molecular mechanisms of hepatic dysfunction in sickle cell disease: lessons from Townes mouse model
Pradhan‐Sundd, T., Kato, G. J., & Novelli, E. M. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00175.2022 · Cited by 16
Hypoxia in breast cancer
Badowska-Kozakiewicz, A. M., Budzik, M. P., & Przybylski, J. (2016) · Polish Journal of Pathology · doi:10.5114/pjp.2015.57245 · Cited by 14
Hepcidin and its multiple partners: Complex regulation of iron metabolism in health and disease
Ginzburg, Y. Z. (2023) · Vitamins and hormones · doi:10.1016/bs.vh.2023.03.001 · Cited by 15
The drug-specific properties of hypoxia-inducible factor-prolyl hydroxylase inhibitors in mice reveal a significant contribution of the kidney compared to the liver to erythropoietin induction
Nakai, T., Saigusa, D., Kato, K., Fukuuchi, T., Koshiba, S., Yamamoto, M. P., & Suzuki, N. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122641 · Cited by 15
The potential role of Na-K-ATPase and its signaling in the development of anemia in chronic kidney disease
Maxwell, K., Chuang, J., Chaudhry, M. A., Nie, Y., Bai, F., Sodhi, K., Liu, J., & Shapiro, J. I. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00244.2020 · Cited by 12
Targeted autophagy disruption reveals the central role of macrophage iron metabolism in systemic iron homeostasis
Taleb, M., Maillet, I., Bert, M. L., & Mura, C. (2022) · Blood · doi:10.1182/blood.2021014493 · Cited by 13
p53 status modifies cytotoxic activity of lactoferrin under hypoxic conditions
Kosim, M. Y., Fukazawa, T., Miyauchi, M., Hirohashi, N., & Tanimoto, K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.988335 · Cited by 12
Hypobaric hypoxia induces iron mobilization from liver and spleen and increases serum iron via activation of ghrelin/GHSR1a/MAPK signalling pathway in mice
Yang, W.-P., Li, J., Hu, J., Yuan, X., Ding, J., Jiang, H., Wang, G., & Luo, Q. (2023) · Scientific Reports · doi:10.1038/s41598-023-47596-6 · Cited by 10
Hypoxia attenuates inflammation-induced hepcidin synthesis during experimental human endotoxemia
Kiers, D., van Eijk, L. T., van der Hoeven, J. G., Swinkels, D. W., Pickkers, P., & Kox, M. (2019) · Haematologica · doi:10.3324/haematol.2018.202796 · Cited by 12
Influence of mitochondrial and systemic iron levels in heart failure pathology
Lupu, M., Tudor, D. V., & Filip, G. A. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09788-z · Cited by 13
Disturbance of Hypoxia Response and Its Implications in Kidney Diseases
Li, Z., Wang, B., Wen, Y., Wu, Q., Lv, L., & Liu, B. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0271 · Cited by 11
Physiological focus on the erythropoietin–hepcidin–ferroportin axis
D’Anna, M. C., & Roque, M. E. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0214 · Cited by 11
Postexercise serum hepcidin response to repeated sprint exercise under normoxic and hypoxic conditions
Goto, K., Kasai, N., Kojima, C., & Ishibashi, A. (2017) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2017-0418 · Cited by 11
Short-Term Effects of Blood Transfusions on Hepcidin in Preterm Infants
Springer, L., Müller, K., Poets, C. F., Peter, A., Olbina, G., Westerman, M. E., & Franz, A. R. (2015) · Neonatology · doi:10.1159/000437132 · Cited by 12
No effect of supplemented heat stress during an acute endurance exercise session in hypoxia on hepcidin regulation
Hayashi, N., Yatsutani, H., Mori, H., Ito, H., Badenhorst, C. E., & Goto, K. (2020) · European Journal of Applied Physiology · doi:10.1007/s00421-020-04365-x · Cited by 11
Chronic intermittent hypobaric hypoxia improves markers of iron metabolism in a model of dietary-induced obesity
Cui, F., Guo, J., Hu, H., Zhang, Y., & Shi, M. Y. (2020) · Journal of Inflammation · doi:10.1186/s12950-020-00265-1 · Cited by 10
Changes of biomarkers for erythropoiesis, iron metabolism, and FGF23 by supplementation with roxadustat in patients on hemodialysis
Yoshida, S., Saito, T., Shibagaki, K., Hirao, K., Yuza, T., Tomosugi, N., & Honda, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-30331-6 · Cited by 10
Genetic disposition and modifiable factors independently associated with anemia in patients with type 2 diabetes mellitus
Chiou, T. T., Lee, J., Wang, M., Chung, M.-S., Pan, L., Hsieh, C., Huang, S.-T., Chang, H., Yang, K. D., Lee, C., et al. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.12.012 · Cited by 10
Hypoxia-inducible factor-1α, hepcidin and interleukin-6 levels in pregnancies with preterm labour
Fırat, A. A., Davutoğlu, E. A., Özel, A., Güngör, Z. B., Madazlı, R., & Zengin, E. (2019) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2019.1672141 · Cited by 10
Post-exercise serum hepcidin levels were unaffected by hypoxic exposure during prolonged exercise sessions
Goto, K., Sumi, D., Kojima, C., & Ishibashi, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183629 · Cited by 10
Recombinant human erythropoietin-induced erythropoiesis regulates hepcidin expression over iron status in the rat
Ribeiro, S., Garrido, P., Fernandes, J. C., Rocha, S., Rocha‐Pereira, P., Costa, E. M., Belo, L., Reis, F., & Santos‐Silva, A. (2016) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2016.04.008 · Cited by 9
Jian‐Pi‐Yi‐Shen Regulates EPO and Iron Recycling Protein Expressions in Anemic Rats with Chronic Kidney Disease: Accumulation of Hypoxia Inducible Factor‐2 α via ERK Signaling
Wang, F., Yu, H., Huang, S., Lin, Z., Zheng, P., Zhang, S., Li, S., & Chen, J. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/8894257 · Cited by 9
Iron and Testosterone: Interplay and Clinical Implications
Gabrielsen, J. S. (2017) · Current Sexual Health Reports · doi:10.1007/s11930-017-0097-2 · Cited by 9
Iron, the Essential Micronutrient: A Comprehensive Review of Regulatory Pathways of Iron Metabolism
Horváth, A., Tamási, K., Pap, R., Jánosa, G., & Pandur, E. (2025) · Nutrients · doi:10.3390/nu18010109 · Cited by 12
The relationships among gut microbiota, hypoxia‐inducible factor and anaemia with chronic kidney disease
Liu, L., Xu, W., Kong, P., & Dou, Y. (2022) · Nephrology · doi:10.1111/nep.14064 · Cited by 8

Authors: Liu, Q., Davidoff, O., Niss, K., & Haase, V. H.
Affiliations: Vanderbilt University (US)
MilliporeSigma (United States) (US)
Corresponding author: Haase, Volker H.
ORCID: Haase, Volker H.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2012-11-01
Volume: 122
Issue: 12
Pages: 4635-4644
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci63924
PMC: PMC3533545
OpenAlex: W2002549547
Cited by: 328
References: 51
Citations by year: 2026: 10 · 2025: 18 · 2024: 18 · 2023: 26 · 2022: 40 · 2021: 25 · 2020: 28 · 2019: 19 · 2018: 22 · 2017: 28 · 2016: 28 · 2015: 20 · 2014: 29 · 2013: 16
FWCI: 13.86
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Journal of Clinical Investigation (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (R01-DK080821)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK080821, R01DK081646, P30DK020593)
Topics: Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
Keywords: hypoxia-inducible factor, hepcidin, erythropoietin, erythropoiesis, iron metabolism, ferroportin, growth differentiation factor 15, hypoxia, iron absorption, liver
MeSH terms: Endothelial PAS Domain-Containing Protein 1, Animals, Erythropoiesis, Erythropoietin, Gene Expression Regulation, Humans, Liver, Procollagen-Proline Dioxygenase, Gene Expression, Mice, Knockout, Hepatocytes, Antimicrobial Cationic Peptides, Cell Line, Tumor, Mice, Basic Helix-Loop-Helix Proteins, Basic Helix-Loop-Helix Transcription Factors, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit, Growth Differentiation Factor 15, Hepcidins, Hypoxia-Inducible Factor-Proline Dioxygenases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks